T10	Disease 400 405	NSCLC
T11	Biomarker 499 513	EGFR mutations
T12	Disease 531 536	NSCLC
T13	Biomarker 560 586	sensitizing EGFR mutations
T14	Disease 648 653	NSCLC
T15	Biomarker 662 675	EGFR mutation
T17	Biomarker 806 820	EGFR mutations
T18	Biomarker 1010 1070	receptor tyrosine-protein kinase erbB-2 (HER2) amplification
T19	Chemical 1019 1027	tyrosine
T2	Biomarker 41 52	Lung cancer
#7	AnnotatorNotes T2	D008175
T21	Variant 1080 1085	T790M
T23	Chemical 1125 1133	tyrosine
T24	Chemical 1164 1201	phosphatidylinositol-4,5-bisphosphate
T25	Chemical 1274 1280	serine
T26	Chemical 1281 1290	threonine
T27	Disease 1318 1323	tumor
#12	AnnotatorNotes T27	DOID:162
T28	Chemical 1461 1469	estrogen
T29	Biomarker 1461 1502	estrogen receptor (ER)β was overexpressed
T3	Disease 77 104	cancer-associated mortality
#14	AnnotatorNotes T3	not found
T30	Disease 1506 1511	NSCLC
T31	Drug-Class 1588 1597	EGFR-TKIs
T32	Disease 1615 1620	NSCLC
T33	Biomarker 1632 1635	ERβ
T34	Disease 1693 1704	lung cancer
T35	Disease 1806 1817	lung cancer
T36	Biomarker 1831 1862	ERβ is frequently overexpressed
T37	Disease 1866 1891	NSCLC with EGFR mutations
T39	Disease 1909 1928	lung adenocarcinoma
#20	AnnotatorNotes T39	DOID:3910
T4	Disease 119 145	non-small cell lung cancer
#21	AnnotatorNotes T4	DOID:3908
T40	Disease 2013 2038	NSCLC with EGFR mutations
T43	Disease 2323 2328	NSCLC
T5	Disease 147 152	NSCLC
#24	AnnotatorNotes T5	DOID:3908
T6	Disease 181 192	lung cancer
#25	AnnotatorNotes T6	DOID:1324
T7	Biomarker 206 282	Mutations and gene amplifications of epidermal growth factor receptor (EGFR)
T8	Disease 303 308	NSCLC
T9	Drug-Class 314 345	EGFR-tyrosine kinase inhibitors
R1	Association Arg1:T2 Arg2:T3	
T1	Gene-Protein 243 275	epidermal growth factor receptor
#1	AnnotatorNotes T1	HGNC:3236
T44	Gene-Protein 277 281	EGFR
#5	AnnotatorNotes T44	HGNC:3236
T45	Gene-Protein 314 318	EGFR
R2	Association Arg1:T7 Arg2:T8	
R3	Response Arg1:T9 Arg2:T10	
T46	Drug-Class 347 356	EGFR-TKIs
T47	Gene-Protein 347 351	EGFR
R4	Association Arg1:T11 Arg2:T12	
T48	Gene-Protein 499 503	EGFR
T49	Drug-Class 615 624	EGFR-TKIs
T50	Gene-Protein 572 576	EGFR
T51	Biomarker 679 704	unknown mutational status
T52	Drug-Class 722 749	platinum-based chemotherapy
T16	Gene-Protein 662 666	EGFR
T53	Gene-Protein 806 810	EGFR
T54	Gene-Protein 852 856	EGFR
T55	Drug-Class 852 861	EGFR-TKIs
T56	Gene-Protein 1051 1055	HER2
#3	AnnotatorNotes T56	HGNC:3430
T57	Gene-Protein 1010 1049	receptor tyrosine-protein kinase erbB-2
#4	AnnotatorNotes T57	HGNC:3430
T20	Gene-Protein 1075 1079	EGFR
R9	Variant-Of Arg1:T20 Arg2:T21	
#6	AnnotatorNotes T21	p.Thr790Met
T58	Gene-Protein 1096 1140	MET proto-oncogene, receptor tyrosine kinase
#8	AnnotatorNotes T58	HGNC:7029
T59	Gene-Protein 1142 1147	c-MET
#9	AnnotatorNotes T59	HGNC:7029
T22	Biomarker 1096 1162	MET proto-oncogene, receptor tyrosine kinase (c-MET) amplification
T60	Gene-Protein 1232 1238	PIK3CA
#10	AnnotatorNotes T60	HGNC:8975
T61	Gene-Protein 1164 1230	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α
#11	AnnotatorNotes T61	HGNC:8975
T62	Biomarker 1164 1248	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA) mutation
T63	Gene-Protein 1299 1303	BRAF
#13	AnnotatorNotes T63	HGNC:1097
T64	Gene-Protein 1252 1297	B-Raf proto-oncogene, serine/threonine kinase
#26	AnnotatorNotes T64	HGNC:1097
T65	Biomarker 1252 1314	B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations
T66	Collection 1096 1314	MET proto-oncogene, receptor tyrosine kinase (c-MET) amplification, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA) mutation or B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations
R10	Association Arg1:T66 Arg2:T27	
R11	Association Arg1:T21 Arg2:T27	
R12	Association Arg1:T18 Arg2:T27	
T67	Gene-Protein 1461 1484	estrogen receptor (ER)β
#27	AnnotatorNotes T67	HGNC:3468
T68	Gene-Protein 1588 1592	EGFR
R14	Mediated-Non-Response Arg1:T31 Arg2:T32	
R15	Mediator Arg1:T31 Arg2:T29	
#15	AnnotatorNotes T33	D047629
T69	Gene-Protein 1632 1635	ERβ
#16	AnnotatorNotes T69	HGNC:3468
R16	Association Arg1:T33 Arg2:T34	
T70	GeneFamily 1677 1679	ER
#28	AnnotatorNotes T70	not found
T71	Gene-Protein 1771 1774	ERβ
T72	Gene-Protein 1779 1783	EGFR
T73	Biomarker 1748 1802	cross-talk between the ERβ and EGFR signaling pathways
R17	Association Arg1:T73 Arg2:T35	
T74	Gene-Protein 1831 1834	ERβ
#18	AnnotatorNotes T37	not found
T38	Gene-Protein 1877 1881	EGFR
R19	Association Arg1:T36 Arg2:T75	
T75	Collection 1866 1928	NSCLC with EGFR mutations, particularly in lung adenocarcinoma
T76	Biomarker 1946 1960	ERβ expression
T77	Gene-Protein 1946 1949	ERβ
R18	Association Arg1:T76 Arg2:T40	
T41	Gene-Protein 2024 2028	EGFR
T78	Drug-Class 2068 2077	EGFR-TKIs
T79	Gene-Protein 2068 2072	EGFR
T42	Gene-Protein 2133 2137	ERβ1
#19	AnnotatorNotes T42	not found
T80	Gene-Protein 2124 2127	ERβ
T81	Gene-Protein 2183 2186	ERβ
T82	Gene-Protein 2292 2295	ERβ
T83	Biomarker 2133 2137	ERβ1
R20	Association Arg1:T83 Arg2:T43	
